These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16955692)

  • 1. An update on angiogenic gene therapy: vascular endothelial growth factor and other directions.
    Ylä-Herttuala S
    Curr Opin Mol Ther; 2006 Aug; 8(4):295-300. PubMed ID: 16955692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy with vascular endothelial growth factors.
    Ylä-Herttuala S
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1198-200. PubMed ID: 19909246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing and targeting of cell-based VEGF165 gene expression in ischemic tissue.
    Spanholtz T; Maichle A; Niedworok C; Stoeckelhuber BM; Krüger S; Wedel T; Aach T; Middeler G; Hellwig-Bürgel T; Bader A; Krengel S; Müller OJ; Franz WM; Lindenmaier W; Machens HG
    J Surg Res; 2009 Jan; 151(1):153-62. PubMed ID: 18621399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for cardiovascular disease: the potential of VEGF.
    Tiong A; Freedman SB
    Curr Opin Mol Ther; 2004 Apr; 6(2):151-9. PubMed ID: 15195927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.
    Shah PB; Losordo DW
    Adv Genet; 2005; 54():339-61. PubMed ID: 16096018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
    Khan TA; Sellke FW; Laham RJ
    Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
    Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
    Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic angiogenesis. Devising new strategies based on past experiences.
    Lei Y; Haider HKh; Shujia J; Sim ES
    Basic Res Cardiol; 2004 Mar; 99(2):121-32. PubMed ID: 14963670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of the ischemic lower limb--Therapeutic angiogenesis.
    Bobek V; Taltynov O; Pinterova D; Kolostova K
    Vascul Pharmacol; 2006 Jun; 44(6):395-405. PubMed ID: 16698324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia.
    Rissanen TT; Rutanen J; Ylä-Herttuala S
    Adv Genet; 2004; 52():117-64. PubMed ID: 15522734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
    Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH
    Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo study of angiogenic plasmid preparations--the bicistronic plasmid as a new type of drug for vascular diseases.
    Małecki M; Swoboda P; Jastrzebski Z; Janik P
    Acta Pol Pharm; 2004; 61(4):289-95. PubMed ID: 15575596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.
    Thébaud B; Ladha F; Michelakis ED; Sawicka M; Thurston G; Eaton F; Hashimoto K; Harry G; Haromy A; Korbutt G; Archer SL
    Circulation; 2005 Oct; 112(16):2477-86. PubMed ID: 16230500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression.
    Bitto A; Minutoli L; Galeano MR; Altavilla D; Polito F; Fiumara T; Calò M; Lo Cascio P; Zentilin L; Giacca M; Squadrito F
    Clin Sci (Lond); 2008 Jun; 114(12):707-18. PubMed ID: 18078386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer as a tool to induce therapeutic vascular growth in plastic surgery.
    Saaristo A; Suominen E; Yla-Herttuala S
    Handchir Mikrochir Plast Chir; 2005 Dec; 37(6):375-82. PubMed ID: 16388452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A balancing act: therapeutic approaches for the modulation of angiogenesis.
    Springer ML
    Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic angiogenesis for ischemic diseases].
    Aoki M; Morishita R
    Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.
    Ylä-Herttuala S; Rissanen TT; Vajanto I; Hartikainen J
    J Am Coll Cardiol; 2007 Mar; 49(10):1015-26. PubMed ID: 17349880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.